Cha Biotech to Acquire Additional Cha Healthcare Shares for 153.9 Billion Won
Cha Biotech announced on June 26 that it will acquire an additional 5,919,732 shares of Cha Healthcare, its overseas healthcare network operation and investment development subsidiary, for approximately 153.9 billion won. After the acquisition, Cha Biotech's stake in Cha Healthcare will increase to 81.7%.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Cha Biotech explained that this share acquisition is "a precedent condition under the share purchase agreement to transfer part of the shares held in our subsidiary, Cha Healthcare Co., Ltd., to the PiumAI Future Healthcare Fund."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.